Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

RJVA-001 was successfully delivered in large animal Yucatan pig models at low total viral dose

Results confirm ability to directly target pancreas with novel delivery catheter and route of administration